| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +4.62M | 42.9% | $18.04 | +$83.3M |
| Sells | 7 | -6.15M | 57.1% | $19.62 | -$121M |
| Net | -2 | -1.53M | -14.2% | -$37.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10%+ Owner | $103M | +$83.1M | +420% | May 6, 2024 |
| EW Healthcare Partners, L.P. | Other*, 10%+ Owner | $87.3M | Sep 1, 2023 | ||
| Ye Liu | Director | $2.51M | -$56.7M | -95.8% | Jan 11, 2024 |
| Therapeutics Ocumension | Director | $2.51M | -$56.7M | -95.8% | Jan 11, 2024 |
| Nancy Lurker | Director | $2M | -$1.26M | -38.8% | Aug 16, 2024 |
| David Scott Jones | SVP & Chief Commercial Officer | $1.44M | -$1.76M | -55% | Feb 9, 2024 |
| Dario A. Paggiarino | Chief Medical Officer | $1.39M | -$2.88M | -67.5% | Mar 30, 2024 |
| Michael Craig Pine | Chief Corp Dev.&Strat. Officer | $965K | -$1.01M | -51.1% | Jan 5, 2024 |
| Jay S. Duker | President and CEO, Director | $816K | Jul 10, 2024 | ||
| George Elston | Chief Financial Officer | $720K | May 25, 2024 | ||
| John B. Landis | Director | $489K | Jan 5, 2024 | ||
| Douglas Godshall | Director | $201K | Jun 22, 2021 | ||
| Karen L. Zaderej | Director | $152K | +$99.8K | +190% | Aug 19, 2024 |
| Goran Ando | Director | $105K | +$39.8K | +61.3% | Aug 21, 2024 |
| Wendy F. Dicicco | Director | $77.6K | +$20K | +34.7% | Aug 20, 2024 |
| Anthony P. Adamis | Director | $61.8K | Jun 23, 2024 | ||
| David R. Guyer | Director | $18.6K | -$384K | -95.4% | Jul 12, 2024 |
| Hassan Fred | Director | Sep 3, 2024 | |||
| Stuart Duty | Director | Jan 5, 2024 | |||
| Adage Capital Management, L.P. | 10%+ Owner | Apr 18, 2024 | |||
| Ramiro Ribeiro | Chief Medical Officer | Mar 1, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|